The CS5371A is a 24-bit geophysical, single channel delta-sigma modulator featuring a clock jitter-tolerant architecture and a dual power supply configuration. If offers high dynamic range ...
CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cavion, Inc., a clinical stage biotechnology company developing novel therapeutics for neurological diseases, announced today that their first ...
Variants of the KCNC1 gene impact K v 3.1 potassium channel function, resulting in neurodevelopmental disorders which can include progressive myoclonic epilepsy (PME) and developmental epileptic ...
Autifony Therapeutics Ltd. has described compounds acting as modulators of voltage-gated potassium channels from the Kv3 subfamily, such as Kv3.1, Kv3.2 and/or Kv3.3, reported to be useful for the ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global ion channel modulators market is entering a decade of sophisticated molecular innovation, with its valuation projected to rise from USD 13.3 billion ...
LONDON, July 25, 2024 (GLOBE NEWSWIRE) -- Kaerus Bioscience Ltd. (www.kaerusbio.com), a clinical-stage biotechnology company focused on developing therapeutics for rare genetic syndromes of ...
When a scrappy team of scientists joined forces in the late 1990s, they sought to identify genetic mutations that could have an outsized impact on the treatment of human disease. At the time, that ...
Bsense Bio Therapeutics Ltd. has nominated BSEN-760, a dual Kv7.2/3 and TRPV1 ion channel modulator, as a clinical candidate for the treatment of chronic pain.
Altera Corporation and Commsonic have announced a partnership to deliver what they describe as the industry’s first multi-channel, single-chip FPGA solution. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results